Menu Menu
 

CDC’s Prostate Cancer Activities-2017

CDC’s prostate cancer funding supports communication initiatives, applied research and surveillance, and prostate cancer activities in the National Comprehensive Cancer Control Program (NCCCP).1 Prostate cancer ranges from a non-aggressive, slow-growing disease that may not require treatment to an aggressive, fast-growing disease that does.2-3 Prostate cancer requires men to make difficult decisions about screening and treatment. For example, if a man is interested in prostate cancer screening with the prostate-specific antigen (PSA) test, clinical opinions may vary on the potential benefits of early detection compared with the potential for harms such as false positives, overdiagnosis, and overtreatment.4-7 Similarly, if a man is newly diagnosed with localized prostate cancer, comparative data from controlled studies are lacking on optimal treatment.1-3 Much of CDC’s surveillance and research activities have focused on learning about prostate cancer screening and treatment practice patterns in the United States (US), and helping to improve knowledge for shared and/or informed decision-making by patients and providers.

Click here for